Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
for Advanced Urothelial Cancer
Drug: GB-4362
Sites in Duarte, Irvine +8 more locations
Sponsor: Generate Biomedicines
Sex: All·Age: 18+
Code: NCT07484022·Phase 1·Recruiting·Listed Mar 2026